I-FDA Ithi Inqaba Ukuqaphela I-CBD Njenge "Ephephile"

-Delile

• Izingozi ezingaba khona ze-CBD
• I-FDA Yehla Kanjani Ku-CBD
• Okufanele Ukwazi Ukuqhubekela Phambili
• Buyekeza kwe-

I-CBD ikhona yonke indawo kulezi zinsuku. Ngaphezu kokuchazwa njengokwelashwa okungenzeka kube khona ukuphathwa kobuhlungu, ukukhathazeka, nokuningi, i-cannabis compound ibilokhu iqoqa kuyo yonke into kusuka emanzini akhazimulayo, iwayini, ikhofi nezimonyo, kuya kwimikhiqizo yezocansi neyezikhathi. Ngisho namaCVS namaWalgreens aqale ukuthengisa imikhiqizo efakwe i-CBD ezindaweni ezikhethiwe ekuqaleni konyaka.

Kepha ukuvuselelwa okusha kwabathengi abavela ku-Food and Drug Administration (FDA) kusho a okuningi ucwaningo olwengeziwe kufanele lwenziwe ngaphambi kokuba i-CBD ibhekwe njengephephile ngempela. "Kunemibuzo eminingi engaphenduleki mayelana nesayensi, ukuphepha kanye nekhwalithi yemikhiqizo equkethe i-CBD," kusho le nhlangano ekubuyekezeni kwayo. "I-FDA ibone idatha elinganiselwe kuphela mayelana nokuphepha kwe-CBD futhi le datha ikhomba ubungozi bangempela okudingeka bucatshangelwe ngaphambi kokuthatha i-CBD nganoma yisiphi isizathu."

Ukuthandwa okwandayo kwe-CBD yisona sizathu esikhulu sokuthi i-FDA ikhethe ukukhipha lesi sixwayiso esiqatha emphakathini manje, ngokusho kokubuyekezwa komthengi wayo. Okukhathaza kakhulu i-ejensi? Abantu abaningi kakhulu bakholelwa ukuthi ukuzama i-CBD "akukwazi ukulimaza," naphezu kokuntuleka kocwaningo oluthembekile, oluphelele mayelana nokuphepha kwe-cannabis compound, i-FDA yachaza ekubuyekezweni kwayo.

Izingozi ezingaba khona ze-CBD

I-CBD ingaba lula ukuyithenga kulezi zinsuku, kepha i-FDA ikhumbuza abathengi ukuthi le mikhiqizo isengalawulwa kakhulu, okwenza kube nzima ukukhomba ngqo ukuthi uwuthinta kanjani umzimba womuntu.

Ekuvuseleleni kwayo okusha komthengi, i-FDA iveze ukukhathazeka okuthile kwezokuphepha, kufaka phakathi ukulimala kwesibindi, ukozela, isifo sohudo, nezinguquko zemizwa. Le nhlangano iphinde yaphawula ukuthi ucwaningo olubandakanya izilwane luphakamise ukuthi i-CBD ingaphazamisa ukuthuthukiswa nokusebenza kwama-testes nesidoda, okungase kwehle amazinga e-testosterone kanye nokonakala kokuziphatha kocansi kwabesilisa ngenxa yalokho. (Okwamanje, i-FDA ithi akucaci ukuthi lokhu okutholakele kuyasebenza nakubantu.)

Lesi sibuyekezo sibuye sathi akukaze kube nocwaningo olwanele ngomthelela i-CBD engaba nawo kwabesifazane abakhulelwe nabancelisayo. Njengamanje, i-ejensi "yeluleka ngokuqinile ngokumelene" nokusebenzisa i-CBD-nensangu nganoma yiluphi uhlobo, ngaleyo ndlela-ngesikhathi sokukhulelwa noma ngenkathi uncelisa. (Okuhlobene: Uyini Umehluko Phakathi Kwe-CBD, iTHC, Insangu, Insangu, neHemp?)

Okokugcina, isibuyekezo esisha sabathengi be-FDA sixwayisa ngokuqinile ngokumelene nokusebenzisa i-CBD ukwelapha izimo zezempilo ezingase zidinge usizo lwezokwelapha olungathi sína noma ukungenelela: "Abathengi bangase bahlehlise ukuthola usizo lwezokwelashwa olubalulekile, njengokuxilongwa okufanele, ukwelashwa nokunakekelwa okusekelwayo ngenxa yezicelo ezingenabufakazi ezihlobene Imikhiqizo ye-CBD, "kukhishwe abezindaba mayelana nokubuyekezwa kwabathengi. "Ngaleso sizathu, kubalulekile ukuthi abathengi bakhulume nodokotela bezempilo mayelana nendlela engcono yokwelapha izifo noma izimo ngezindlela zokwelashwa esezikhona, ezigunyaziwe."

I-FDA Yehla Kanjani Ku-CBD

Ngenxa yokwentuleka okukhulu kwemininingwane yesayensi ngokuphepha kwe-CBD, i-FDA ithi iphinde yathumela izincwadi eziyisixwayiso ezinkampanini eziyi-15 okwamanje ezithengisa ngokungemthetho imikhiqizo ye-CBD e-U.S.

Eziningi zalezi zinkampani zonke ezingenabufakazi zithi imikhiqizo yazo "ivimbela, ixilonge, inciphise, yelaphe noma yelaphe izifo ezibucayi, njengomdlavuza," ephula umthetho othi Federal Food, Drug, and Cosmetic Act, ngokusho kokubuyekezwa kwabathengi be-FDA.

Ezinye zalezi zinkampani nazo zimaketha i-CBD njengesengezo sokudla kanye / noma isithasiselo sokudla, i-FDA ethi asikho emthethweni — isikhathi. "Ngokusekelwe ekuntulekeni kolwazi lwesayensi olusekela ukuphepha kwe-CBD ekudleni, i-FDA ayikwazi ukuphetha ngokuthi i-CBD ngokuvamile yaziwa njengephephile (GRAS) phakathi kochwepheshe abaqeqeshiwe ngokusetshenziswa kwayo ekudleni kwabantu noma kwezilwane," sifunda isitatimende esivela kwabezindaba ze-FDA. khulula.

"Izenzo zanamuhla ziza njengoba i-FDA iqhubeka nokuhlola izindlela ezingaba khona zezinhlobo ezahlukahlukene zemikhiqizo ye-CBD ezomakethwa ngokusemthethweni," kuqhuba isitatimende. "Lokhu kufaka phakathi umsebenzi oqhubekayo wokuthola nokuhlola imininingwane ukuze kubhekwane nemibuzo esilele ephathelene nokuphepha kwemikhiqizo ye-CBD ngenkathi kugcinwa izindinganiso eziqinile zezempilo zomphakathi."

Okufanele Ukwazi Ukuqhubekela Phambili

Kuyaqapheleka ukuthi njenganamuhla, kukhona kuphela eyodwa Umkhiqizo we-CBD ogunyazwe yi-FDA, futhi ubizwa nge-Epidiolex. Umuthi kadokotela usetshenziselwa ukwelapha izinhlobo ezimbili ezingavamile kodwa ezinzima zesifo sokuwa kubantu abaneminyaka emibili ubudala nangaphezulu. Yize umuthi usize iziguli, i-FDA ixwayise esibuyekezweni sayo esisha sabathengi ukuthi omunye wemiphumela engemihle yomuthi uhlanganisa amathuba okwanda kwengozi yokulimala kwesibindi. Kodwa-ke, i-ejensi inqume ukuthi "izingozi zidlula izinzuzo" zalabo abaphuza imithi, nokuthi lezi zingozi zingalawulwa ngokuphephile uma umuthi uthathwa ngaphansi kokuqondisa kwezokwelapha, ngokwesibuyekezo somthengi.

Ngezansi? Yize i-CBD isengumkhuba wokuphila kahle, kusekhona eziningi okungaziwa ngemuva komkhiqizo nezingozi zawo ezingaba khona. Lokho kusho ukuthi, uma usakholelwa ku-CBD nezinzuzo zayo, kufanele ufunde ukuthi ungayithenga kanjani imikhiqizo ephephe futhi esebenza kahle ngangokunokwenzeka.

Buyekeza kwe-